891 European startups raised seed or Series A money in 2025 — the UK alone accounts for 240

Asked:

“Find a list of all the startups headquartered in Europe that raised seed or series A funding in 2025. Exclude biotech or pharmaceutical startups from the report.”

An open-web census found 891 unique European-headquartered startups with a round reported as Seed (including extensions, excluding pre-seed) or Series A in 2025, across 32 countries, after removing companies described as biotech or pharma. Treat it as broad coverage of what the open web reports, not a mathematically complete market count: undisclosed or unindexed rounds may be missing. 453 of the 891 companies are corroborated by two or more independent pages.

Where the 891 funded startups are headquartered

The UK leads with 240 companies, followed by Germany (136), France (74) and Switzerland (51); together these four hold 501 of 891 startups — 56% of the census. funding.tech.eu

Seed outnumbers Series A roughly 3:2 — 541 seed-stage rounds (including extensions) versus 350 Series A rounds. idea-london.co.uk

The largest reported rounds dwarf the typical deal: Fidra Energy (£445m seed, UK battery storage), Verdiva Bio ($410m Series A, UK) and FluidStack and Lovable at $200m Series A each. idea-london.co.uk

September was the busiest reported month with 109 rounds; 44 companies disclosed no round amount at all, and amounts stay in their original currencies here — euros, pounds, dollars, kronor — rather than being summed. funding.tech.eu

All 891 startups

Filters above also apply here. Click a header to sort. Blank cells mean the source did not resolve that detail. Amounts are shown exactly as the source gave them, in the original currency.

Company	Country	Stage	Amount (as reported)	Date	Sector	Pages	Source

Method: open-web census, 891 deduplicated rows merged by normalized company name from four broad multilingual searches (Europe overall; UK & Ireland; Western/Southern Europe; Nordic/Baltic/Central/Eastern/Southeastern Europe), compiled 2025–2026. Europe includes the UK, Ireland, Switzerland, Nordics, Baltics, Balkans and microstates. One row per startup; stage is the source's label grouped to Seed (incl. extensions) or Series A; pre-seed, biotech and pharmaceutical companies were excluded, while ordinary health software, medical devices and diagnostics were kept unless explicitly biotech/pharma. Amounts stay in the source's original currency and are never summed; "Pages" counts corroborating pages per company. Private, undisclosed or ambiguously staged rounds may be absent and some source-labeling errors may remain. Investors and headquarters-city columns were cut for space; they appear in each row's source.

This report was generated automatically by Keenable SELECT at a user's request, from publicly available web sources linked herein. Keenable does not review, verify, or endorse its contents and makes no representation as to accuracy, completeness, or timeliness; AI-based extraction may contain errors. Nothing in this report is investment, legal, financial, or other professional advice. All trademarks and referenced content remain the property of their respective owners; no affiliation or endorsement is implied. To report an error, rights concern, or request removal: legal@keenable.ai.